PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 20, 2020Journal of the American Academy of Dermatology398 citationsOpen Access

Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial

View Full Paper
APAmy S. PallerESElaine C. SiegfriedDTDiamant Thaçi

Key Points

Key points are not available for this paper at this time.

Abstract

Dupilumab + TCS is efficacious and well tolerated in children with severe AD, significantly improving signs, symptoms, and QOL.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Paller et al. (2020) studied this question.

synapsesocial.com/papers/69d77f44b1cb92dd1bb8b6ebhttps://doi.org/10.1016/j.jaad.2020.06.054
Ask AI
Helpful
Bookmark
Share
View Full Paper